BACKGROUND: In comparison with late-onset Alzheimer's disease (LOAD, onset, >65 years), early-age-of-onset Alzheimer's disease (EOAD, onset, <65 years) more often presents with language, visuospatial, and/or executive impairment, often occurring earlier than a progressive memory deficit. The logopenic variant of primary progressive aphasia (lv-PPA) and posterior cortical atrophy (PCA) have recently been described as possible atypical variants of EOAD. Lv-PPA is characterized by isolated language deficit, whereas PCA is characterized by predominant visuospatial deficits. Severe hemispheric gray matter (GM) atrophy associated with EOAD, lv-PPA, and PCA has been described, but regional patterns of white matter (WM) damage are still poorly understood. METHODS: Using structural magnetic resonance imaging and voxel-based morphometry, we investigated WM damage in patients with EOAD (n = 16), PCA (n = 13), lv-PPA (n = 10), and LOAD (n = 14) at presentation and 72 age-matched control subjects. RESULTS: In patients with EOAD, PCA, and lv-PPA, WM atrophy was centered on the lateral temporal and parietal regions, including the cingulum and posterior corpus callosum. Compared with control subjects, patients with lv-PPA showed more severe left parietal damage, and patients with PCA showed more severe occipital atrophy. Moreover, patients with EOAD had greater cingulum atrophy compared with those with LOAD. LOAD showed WM damage in the medial temporal regions and less extensive hemispheric involvement. CONCLUSION: Patterns of WM damage in EOAD, lv-PPA, and PCA are consistent with the clinical syndromes and GM atrophy patterns. WM injury in AD atypical variants may contribute to symptoms and disease pathogenesis.
BACKGROUND: In comparison with late-onset Alzheimer's disease (LOAD, onset, >65 years), early-age-of-onset Alzheimer's disease (EOAD, onset, <65 years) more often presents with language, visuospatial, and/or executive impairment, often occurring earlier than a progressive memory deficit. The logopenic variant of primary progressive aphasia (lv-PPA) and posterior cortical atrophy (PCA) have recently been described as possible atypical variants of EOAD. Lv-PPA is characterized by isolated language deficit, whereas PCA is characterized by predominant visuospatial deficits. Severe hemispheric gray matter (GM) atrophy associated with EOAD, lv-PPA, and PCA has been described, but regional patterns of white matter (WM) damage are still poorly understood. METHODS: Using structural magnetic resonance imaging and voxel-based morphometry, we investigated WM damage in patients with EOAD (n = 16), PCA (n = 13), lv-PPA (n = 10), and LOAD (n = 14) at presentation and 72 age-matched control subjects. RESULTS: In patients with EOAD, PCA, and lv-PPA, WM atrophy was centered on the lateral temporal and parietal regions, including the cingulum and posterior corpus callosum. Compared with control subjects, patients with lv-PPA showed more severe left parietal damage, and patients with PCA showed more severe occipital atrophy. Moreover, patients with EOAD had greater cingulum atrophy compared with those with LOAD. LOAD showed WM damage in the medial temporal regions and less extensive hemispheric involvement. CONCLUSION: Patterns of WM damage in EOAD, lv-PPA, and PCA are consistent with the clinical syndromes and GM atrophy patterns. WM injury in AD atypical variants may contribute to symptoms and disease pathogenesis.
Authors: F Agosta; E Scola; E Canu; A Marcone; G Magnani; L Sarro; M Copetti; F Caso; C Cerami; G Comi; S F Cappa; A Falini; M Filippi Journal: Cereb Cortex Date: 2011-10-10 Impact factor: 5.357
Authors: G B Frisoni; C Testa; F Sabattoli; A Beltramello; H Soininen; M P Laakso Journal: J Neurol Neurosurg Psychiatry Date: 2005-01 Impact factor: 10.154
Authors: Randy L Buckner; Abraham Z Snyder; Benjamin J Shannon; Gina LaRossa; Rimmon Sachs; Anthony F Fotenos; Yvette I Sheline; William E Klunk; Chester A Mathis; John C Morris; Mark A Mintun Journal: J Neurosci Date: 2005-08-24 Impact factor: 6.167
Authors: T Duning; T Warnecke; S Mohammadi; H Lohmann; H Schiffbauer; H Kugel; S Knecht; E B Ringelstein; M Deppe Journal: J Neurol Neurosurg Psychiatry Date: 2009-04 Impact factor: 10.154
Authors: M L Gorno-Tempini; S M Brambati; V Ginex; J Ogar; N F Dronkers; A Marcone; D Perani; V Garibotto; S F Cappa; B L Miller Journal: Neurology Date: 2008-07-16 Impact factor: 9.910
Authors: Raffaella Migliaccio; Federica Agosta; Katherine L Possin; Elisa Canu; Massimo Filippi; Gil D Rabinovici; Howard J Rosen; Bruce L Miller; Maria Luisa Gorno-Tempini Journal: J Alzheimers Dis Date: 2015 Impact factor: 4.472
Authors: Hugo Botha; Joseph R Duffy; Jennifer L Whitwell; Edythe A Strand; Mary M Machulda; Christopher G Schwarz; Robert I Reid; Anthony J Spychalla; Matthew L Senjem; David T Jones; Val Lowe; Clifford R Jack; Keith A Josephs Journal: Cortex Date: 2015-05-27 Impact factor: 4.027
Authors: D T Ohm; G Kim; T Gefen; A Rademaker; S Weintraub; E H Bigio; M-M Mesulam; E Rogalski; C Geula Journal: Neuropathol Appl Neurobiol Date: 2018-05-17 Impact factor: 8.090
Authors: Talia M Nir; Julio E Villalon-Reina; Gautam Prasad; Neda Jahanshad; Shantanu H Joshi; Arthur W Toga; Matt A Bernstein; Clifford R Jack; Michael W Weiner; Paul M Thompson Journal: Neurobiol Aging Date: 2014-08-27 Impact factor: 4.673
Authors: I Suridjan; B G Pollock; N P L G Verhoeff; A N Voineskos; T Chow; P M Rusjan; N J Lobaugh; S Houle; B H Mulsant; R Mizrahi Journal: Mol Psychiatry Date: 2015-02-24 Impact factor: 15.992
Authors: Irene Sintini; Christopher G Schwarz; Peter R Martin; Jonathan Graff-Radford; Mary M Machulda; Matthew L Senjem; Robert I Reid; Anthony J Spychalla; Daniel A Drubach; Val J Lowe; Clifford R Jack; Keith A Josephs; Jennifer L Whitwell Journal: Hum Brain Mapp Date: 2018-12-13 Impact factor: 5.038
Authors: Henrik Zetterberg; Tobias Skillbäck; Niklas Mattsson; John Q Trojanowski; Erik Portelius; Leslie M Shaw; Michael W Weiner; Kaj Blennow Journal: JAMA Neurol Date: 2016-01 Impact factor: 18.302